#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
proLékaře.cz

Athero Review - Issue 2/2021

Editorial

63
EDITORIAL

Reviews

67
Hypolipidemic treatment improves the prognosis of diabetics. Why do we use it so modestly?

Richard Češka, Jiří Šilar

73
Insulin resistance and its targeting in clinical practice

Jan Škrha Jr

76
SGLT2 inhibitors and atherosclerosis in a background of effect of gliflozins and heart failure

Josef Kořínek, Miloš Dobiáš

84
The LDL number is alive!

Richard Češka

90
Atherosclerosis – indicator for treatment of patient with type 2 diabetes mellitus

Katarína Rašlová

95
Residual inflammatory cardiovascular risk – diagnostic and therapeutic challenge

Ján Murín, Jozef Bulas, Martin Wawruch, Udovít Gašpar

99
Physical activity in treatment and prevention with a focus on risk factors for cardiovascular disease

Martin Matoulek

103
New alirocumab dosing regimen: 300 mg every 4 weeks

Petr Ošťádal

108
Research on remarkable articles from international literature

Eva Tůmová

Announcements

110
24. virtuálny kongres XI. škola lipidológie a XXIX. nové trendy v prevencii aterosklerózy 2021

Katarína Gonová

Athero Review

Issue 2
2021 Issue 2
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#